Assessment of Research Digest Impact for Minority with Prostate Cancer, MiCAP Phase III Study

NCT05895279 | Completed

• 3 other identifiers: 21-006715NCI-2022-09906MiCaP
• Study Type: interventional
• Target: 220
• Locations: 1 country
• Sites: 1

Brief Summary

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Conditions

Prostate Carcinoma

Outcome Measures

Primary Outcomes (4)

• Change in perception of access to medical services and general health

  Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding access to medical services and general health with a yes/no response.

  Baseline, 1 hour after video intervention

• Change in perception in participation with clinical trials about prostate cancer

  Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding views on participating in clinical trials about prostate cancer with a yes/no response.

  Baseline, 1 hour after video intervention

• Change in perception of familiarity with prostate cancer research

  Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding views on participating in clinical trials about prostate cancer with a true/false/don't know response.

  Baseline, 1 hour after video intervention

• Change in perception of familiarity with a research study protocol

  Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding information about a study protocol with a true/false/don't know response.

  Baseline, 1 hour after video intervention

Study Arms (2)

MiCaP Research Digest Video Group

EXPERIMENTAL

Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial.

Other: Media Intervention; Other: Survey Administration

Alternate Video Group

ACTIVE COMPARATOR

Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Other: Media Intervention; Other: Survey Administration

Interventions

Media Intervention OTHER

Watch MiCaP Research Digest video

MiCaP Research Digest Video Group

Survey Administration OTHER

Complete survey

Alternate Video Group; MiCaP Research Digest Video Group

Eligibility Criteria

• Age: 35 Years - 70 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Identify as a Black male
• Between the ages of 35 and 70
• For virtual data collection, have access to the internet and Zoom (if joining study online)
• For virtual data collection, reside anywhere in the U.S.
• For in-person data collection, reside in one of the nine (9) catchment areas of the Mayo Clinic Cancer Center: Baker, Duval, Nassau, Clay, St. John's, Putnam, Flagler, Volusia and Brevard

You may not qualify if:

• Identify as a race or ethnicity that is not Black
• Identify as female
• Be younger than age 35 and older than age 70
• Lack access to internet and Zoom (if joining study online)

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980, United States

Location

Related Links

• Mayo Clinic Clinical Trials

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Study Officials

• Folakemi T. Odedina, Ph.D.

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 17, 2023
• First Posted: June 8, 2023
• Study Start: August 2, 2021
• Primary Completion: October 1, 2021
• Study Completion: October 1, 2021
• Last Updated: November 4, 2024

Record last verified: 2024-10

Locations

US (1)